You are here
Pfizer beats Sanofi to buy Medivation for US$14b
PFIZER Inc has agreed to buy Medivation Inc for about US$14 billion, gaining a blockbuster prostate cancer treatment and leaving French drugmaker Sanofi jilted.
Pfizer will pay US$81.50 a share in cash, the companies said in a statement on Monday. Shares of Medivation,
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org